Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$183.51
+2.4%
$178.10
$127.59
▼
$193.07
$49.39B0.211.77 million shs1.46 million shs
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$43.88
-1.8%
$46.96
$42.20
▼
$105.65
$64.75B0.5720.29 million shs15.20 million shs
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
$82.44
-0.1%
$91.31
$79.27
▼
$186.81
$76.65B0.91189,539 shs182,723 shs
Terumo Corp. stock logo
TRUMY
Terumo
$14.59
+2.3%
$15.05
$12.08
▼
$17.81
$21.03B0.6866,397 shs66,377 shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
+2.26%+1.60%-3.53%+17.59%-1.30%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
-1.87%+1.09%-9.00%-0.65%-55.23%
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
-0.13%+3.61%-11.07%-13.84%-47.75%
Terumo Corp. stock logo
TRUMY
Terumo
+2.31%+3.04%-9.32%+6.30%-11.36%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$183.51
+2.4%
$178.10
$127.59
▼
$193.07
$49.39B0.211.77 million shs1.46 million shs
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$43.88
-1.8%
$46.96
$42.20
▼
$105.65
$64.75B0.5720.29 million shs15.20 million shs
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
$82.44
-0.1%
$91.31
$79.27
▼
$186.81
$76.65B0.91189,539 shs182,723 shs
Terumo Corp. stock logo
TRUMY
Terumo
$14.59
+2.3%
$15.05
$12.08
▼
$17.81
$21.03B0.6866,397 shs66,377 shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
+2.26%+1.60%-3.53%+17.59%-1.30%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
-1.87%+1.09%-9.00%-0.65%-55.23%
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
-0.13%+3.61%-11.07%-13.84%-47.75%
Terumo Corp. stock logo
TRUMY
Terumo
+2.31%+3.04%-9.32%+6.30%-11.36%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
2.41
Hold$187.672.27% Upside
Boston Scientific Corporation stock logo
BSX
Boston Scientific
2.68
Moderate Buy$70.1959.96% Upside
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
2.63
Moderate BuyN/AN/A
Terumo Corp. stock logo
TRUMY
Terumo
3.00
BuyN/AN/A

Current Analyst Ratings Breakdown

Latest TRUMY, ESLOY, BSX, and BDX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/23/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Lower Price TargetEqual Weight$50.00 ➝ $48.00
9/22/2026
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
Reiterated RatingOutperform
9/21/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Lower Price TargetOutperform$85.00 ➝ $65.00
9/17/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Reiterated RatingBuy
9/17/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
DowngradeBuy ➝ Neutral$57.00 ➝ $50.00
9/17/2026
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
DowngradeStrong-Buy ➝ Strong Sell
9/9/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Lower Price TargetBuy$60.00 ➝ $56.00
8/31/2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Boost Price TargetNeutral$185.00 ➝ $200.00
8/25/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Reiterated RatingBuy$56.00
8/18/2026
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
UpgradeStrong Sell ➝ Hold
8/13/2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Reiterated RatingBuy
(Data available from 9/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$21.84B2.32$23.62 per share7.77$88.58 per share2.07
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$20.07B3.17$3.96 per share11.07$16.49 per share2.66
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
$32.23B2.38$7.65 per share10.78$48.22 per share1.71
Terumo Corp. stock logo
TRUMY
Terumo
$7.52B2.86$1.06 per share13.73$7.09 per share2.06
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$1.68B$3.3255.2713.8612.634.52%14.79%6.93%11/5/2026 (Estimated)
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$2.90B$2.4717.7712.911.0717.50%19.28%10.89%10/28/2026 (Estimated)
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
$2.62BN/AN/A18.202.36N/AN/AN/AN/A
Terumo Corp. stock logo
TRUMY
Terumo
$897.03M$0.7120.5519.45N/A13.83%10.44%7.34%11/11/2026 (Estimated)

Latest TRUMY, ESLOY, BSX, and BDX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2026Q1 2027
Terumo Corp. stock logo
TRUMY
Terumo
$0.17$0.30+$0.13$0.30$1.84 billion$1.97 billion
8/6/2026Q3 2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$3.14$3.23+$0.09$1.37$4.89 billion$4.98 billion
7/29/2026Q2 2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$0.83$0.86+$0.03$0.61$5.38 billion$5.44 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$4.202.29%+5.65%126.51%53 Years
Boston Scientific Corporation stock logo
BSX
Boston Scientific
N/AN/AN/AN/AN/A
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
$1.672.03%N/AN/AN/A
Terumo Corp. stock logo
TRUMY
Terumo
$0.110.75%N/A15.49%N/A

Latest TRUMY, ESLOY, BSX, and BDX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/28/2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
quarterly$1.052.33%9/9/20269/9/20269/30/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.55
0.87
0.51
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.43
1.24
0.74
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
0.17
0.99
0.70
Terumo Corp. stock logo
TRUMY
Terumo
0.13
2.19
1.37

Institutional Ownership

CompanyInstitutional Ownership
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
86.97%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
89.07%
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
0.01%
Terumo Corp. stock logo
TRUMY
Terumo
N/A

Insider Ownership

CompanyInsider Ownership
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.40%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.34%
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
N/A
Terumo Corp. stock logo
TRUMY
Terumo
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
72,000275.54 million274.44 millionOptionable
Boston Scientific Corporation stock logo
BSX
Boston Scientific
59,0001.45 billion1.44 billionOptionable
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
203,791928.49 millionN/ANot Optionable
Terumo Corp. stock logo
TRUMY
Terumo
30,0001.48 billionN/ANot Optionable

Recent News About These Companies

Terumo ADR (TRUMY)
Terumo (OTCMKTS:TRUMY) Shares Gap Up on Strong Earnings
Terumo ADR Stock Price History
Terumo Corporation (TRUMY) Q3 2026 Earnings Call Transcript
Terumo Corporation (TRUMY) Q2 2026 Earnings Call Transcript
Terumo Corp ADR TRUMY

New MarketBeat Followers Over Time

Media Sentiment Over Time

Becton, Dickinson and Company stock logo

Becton, Dickinson and Company NYSE:BDX

$183.51 +4.28 (+2.39%)
Closing price 09/25/2026 03:59 PM Eastern
Extended Trading
$184.41 +0.90 (+0.49%)
As of 09/25/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Boston Scientific stock logo

Boston Scientific NYSE:BSX

$43.88 -0.80 (-1.79%)
Closing price 09/25/2026 03:59 PM Eastern
Extended Trading
$43.98 +0.10 (+0.22%)
As of 09/25/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

EssilorLuxottica stock logo

EssilorLuxottica OTCMKTS:ESLOY

$82.44 -0.11 (-0.13%)
As of 09/25/2026 03:59 PM Eastern

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, and Optifog brands. It also provides finishing equipment, vision performance screening, eye examination and refractions, fitting parameter measurements, and small tools and consumables under the Essilor Instruments brand; high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. In addition, the company provides eyewear products under the Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native, Luxottica, Sferoflex, Bolon, Molsion, DbyD, and Unofficial and Seen, as well as other Licensed brands. In addition, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It wholesales its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and sells directly to consumers through the network of brick and mortar retail network and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.

Terumo stock logo

Terumo OTCMKTS:TRUMY

$14.59 +0.33 (+2.31%)
As of 09/25/2026 03:58 PM Eastern

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.